Clinical Outcome in Ischemic Stroke Predicted by Early Diffusion-Weighted and Perfusion Magnetic Resonance Imaging: A Preliminary Analysis

Perfusion and diffusion-weighted magnetic resonance imaging (MRI) can demonstrate, respectively, cerebral ischemia and ischemic brain injury in the first several hours after onset of symptoms, when proton density and T2-weighted MRI may appear normal. It is hypothesized that these techniques could distinguish regions destined for infarction from those that will not progress to infarction. We provide preliminary evidence from an analysis of 19 patients with severely disabling clinical deficits attributable to ischemia in at least an entire division of the middle cerebral artery, that initial perfusion and diffusion MRI were more accurate than conventional MRI in predicting no, partial or complete improvement—17 of 19 cases (p < 0.0001) versus 10 of 19 cases, respectively. In the subset of patients studied within 6 h of onset, diffusion/perfusion MRI was an even better predictor than conventional MRI—11 of 12 versus four of 12, respectively. In this small sample of patients with severe clinical deficits, perfusion and diffusion MRI were highly accurate in distinguishing those who would improve from those who would not. These results need to be confirmed in a larger prospective study, which may support a future role in the initial screening, selection, and evaluation of patients with stroke for acute pharmacologic interventions.

[1]  G. Marchal,et al.  PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome , 1993, The Lancet.

[2]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[3]  R. C. Collins,et al.  Selective vulnerability of the brain: new insights into the pathophysiology of stroke. , 1989, Annals of internal medicine.

[4]  E. Lo,et al.  Pharmacologic Reversal of Acute Changes in Diffusion-Weighted Magnetic Resonance Imaging in Focal Cerebral Ischemia , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  Honig Ls Ischemic brain damage. , 1991 .

[6]  Wei Li,et al.  Acute cerebral ischemia: evaluation with dynamic contrast-enhanced MR imaging and MR angiography. , 1992, Radiology.

[7]  J. Bogousslavsky,et al.  Evolving toward effective therapy for acute ischemic stroke. , 1993, JAMA.

[8]  M E Moseley,et al.  Early detection of ischemic injury: comparison of spectroscopy, diffusion-, T2-, and magnetic susceptibility-weighted MRI in cats. , 1990, Acta neurochirurgica. Supplementum.

[9]  S. Williams,et al.  Diffusion‐Weighted Imaging Studies of Cerebral Ischemia in Gerbils: Potential Relevance to Energy Failure , 1992, Stroke.

[10]  C. Sotak,et al.  Diffusion and Perfusion Magnetic Resonance Imaging Studies to Evaluate a Noncompetitive N‐Methyl‐D‐aspartate Antagonist and Reperfusion in Experimental Stroke in Rats , 1993, Stroke.

[11]  S. Levine,et al.  Thrombolytic therapy in cerebrovascular disorders. , 1992, Progress in cardiovascular diseases.

[12]  J. Marler,et al.  Urgent Therapy for Stroke: Part II. Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes From Onset , 1992, Stroke.

[13]  C. Sotak,et al.  Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion‐weighted MRI , 1993, Neurology.

[14]  J. Tsuruda,et al.  Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. , 1990, Radiology.

[15]  W. Pulsinelli,et al.  Pathophysiology of acute ischaemic stroke , 1992, The Lancet.

[16]  J. Broderick,et al.  Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes , 1992, Stroke.

[17]  K. Hossmann,et al.  Diffusion nuclear magnetic resonance imaging in experimental stroke. Correlation with cerebral metabolites. , 1994, Stroke.

[18]  J. Kurhanewicz,et al.  Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. , 1990, AJNR. American journal of neuroradiology.

[19]  B. Siewert,et al.  Acute human stroke studied by whole brain echo planar diffusion‐weighted magnetic resonance imaging , 1995, Annals of neurology.

[20]  K Minematsu,et al.  Diffusion‐weighted magnetic resonance imaging , 1992, Neurology.

[21]  Wei Li,et al.  Fast magnetic resonance diffusion‐weighted imaging of acute human stroke , 1992, Neurology.

[22]  W. Yuh,et al.  MR imaging of cerebral ischemia: findings in the first 24 hours. , 1991, AJNR. American journal of neuroradiology.

[23]  B. Rosen,et al.  Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.

[24]  J W Belliveau,et al.  Functional cerebral imaging by susceptibility‐contrast NMR , 1990, Magnetic resonance in medicine.

[25]  B. Siesjö,et al.  Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. , 1992, Journal of neurosurgery.

[26]  R N Bryan,et al.  Diagnosis of Acute Cerebral Infarction : Comparison of CT and MR Imaging 611 , 2013 .

[27]  L. Honig Ischemic brain damage. , 1991, Neurology.

[28]  J. Kucharczyk,et al.  Ischemic brain damage: reduction by sodium-calcium ion channel modulator RS-87476. , 1991, Radiology.

[29]  H. B. Verheul,et al.  Changes in metabolites and tissue water status after focal ischemia in cat brain assessed with localized proton MR spectroscopy , 1994, Magnetic resonance in medicine.

[30]  R R Edelman,et al.  Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. , 1990, Radiology.